In a filing, Tenet Healthcare Corp revealed its CEO Sutaria Saumya unloaded Company’s shares for reported $15.03 million on Sep 10 ’25. In the deal valued at $190.78 per share,78,762 shares were sold. As a result of this transaction, Sutaria Saumya now holds 368,683 shares worth roughly $75.44 million.
Then, Sutaria Saumya bought 78,762 shares, generating $15,025,892 in total proceeds.
Before that, Lynch Christopher S. sold 8 shares. Tenet Healthcare Corp shares valued at $1,468 were divested by the Director at a price of $183.44 per share. As a result of the transaction, Lynch Christopher S. now holds 12,350 shares, worth roughly $2.53 million.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Peer perform”. Wells Fargo also remained covering THC and has increased its forecast on May 29, 2025 with a “an Overweight” recommendation from previously “an Equal weight” rating. Robert W. Baird revised its rating on April 15, 2025. It rated THC as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of THC
On Tuesday, Tenet Healthcare Corp [NYSE:THC] saw its stock fall -5.34% to $204.62. Over the last five days, the stock has gained 1.12%. Tenet Healthcare Corp shares have risen nearly 35.43% since the year began. Nevertheless, the stocks have risen 62.10% over the past one year. While a 52-week high of $217.43 was reached on 10/24/25, a 52-week low of $109.82 was recorded on 04/21/25.
Levels Of Support And Resistance For THC Stock
The 24-hour chart illustrates a support level at 197.39, which if violated will result in even more drops to 190.15. On the upside, there is a resistance level at 212.92. A further resistance level may holdings at 221.21.
How much short interest is there in Tenet Healthcare Corp?
A steep rise in short interest was recorded in Tenet Healthcare Corp stocks on 2025-10-15, growing by 28482.0 shares to a total of 2.55 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.52 million shares. There was a rise of 1.12%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 26, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $165 price target.
